Delivery Order SPE2DB20D3303-SPE2DB25FA3QE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram units, with a ceiling value of $2,029.18. This is a firm fixed price, non-set-aside contract with a completion date of August 29, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Proctofoam-HC 1%-1% foam in a 10-gram unit, with a ceiling value of $1,048.10. This competitively awarded contract uses firm fixed pricing and is classified as a non-set-aside procurement. The delivery order is expected to be completed by August 18, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,724.56 on September 3, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 4, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,327.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for Proctofoam-HC 1%-1% Foam in 10-gram units. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,832.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram units. This non-set-aside delivery order, which must be completed by September 9, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving military...
- The Defense Logistics Agency awarded a $1,257.60 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram quantities. This is a firm fixed price, non-set-aside contract with a completion date of September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award leverages AmerisourceBergen Drug Corp's existing relationship with...
- The Defense Logistics Agency awarded a delivery order valued at $3,450.84 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram units. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The ultimate completion date is set for September 12, 2025, and the product will be performed and delivered from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,048.00 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a non-set-aside contract with an ultimate completion date of September 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor...
- The Defense Logistics Agency awarded a $2,420.48 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Proctofoam-HC 1%-1% Foam in a 10-gram formulation. This firm fixed-price contract is classified as a non-set-aside procurement and is scheduled for completion by August 26, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit, valued at $1,060.08 under a firm fixed price contract. This delivery order represents a non-set-aside award issued to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. The award serves military and federal healthcare supply needs through DLA's...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3QEDelivery Order
The Defense Logistics Agency awarded a $1,454.25 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of the Defense Logistics Agency's Medical Supply Chain operations, which procures pharmaceuticals and medical supplies to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As the prime contractor under this comprehensive global pharmaceutical support vehicle, AmerisourceBergen Drug Corp supplies a broad range of medications, medical devices, and healthcare commodities to support military health programs worldwide. The company's federal contracting history demonstrates consistent competitive success across multiple therapeutic domains, positioning it as a critical vendor within the federal medical procurement landscape.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/12/25 |